Thomas Steger‐Hartmann

3.8k total citations · 1 hit paper
58 papers, 2.4k citations indexed

About

Thomas Steger‐Hartmann is a scholar working on Computational Theory and Mathematics, Small Animals and Molecular Biology. According to data from OpenAlex, Thomas Steger‐Hartmann has authored 58 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Computational Theory and Mathematics, 15 papers in Small Animals and 9 papers in Molecular Biology. Recurrent topics in Thomas Steger‐Hartmann's work include Computational Drug Discovery Methods (16 papers), Animal testing and alternatives (15 papers) and Lanthanide and Transition Metal Complexes (7 papers). Thomas Steger‐Hartmann is often cited by papers focused on Computational Drug Discovery Methods (16 papers), Animal testing and alternatives (15 papers) and Lanthanide and Transition Metal Complexes (7 papers). Thomas Steger‐Hartmann collaborates with scholars based in Germany, Switzerland and United States. Thomas Steger‐Hartmann's co-authors include Klaus Kümmerer, R. Länge, Hermann Schweinfurth, Matthew Clark, Michael Meyer, Andreas Hartmann, Hubertus Pietsch, Martin A. Sieber, Nikolaus Heinrich and Andreas Sutter and has published in prestigious journals such as Water Research, Nature Reviews Drug Discovery and Advanced Drug Delivery Reviews.

In The Last Decade

Thomas Steger‐Hartmann

55 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The evolving role of investigative toxicology in the pharmaceutical industry

2023 132 citations Mario Beilmann, Harrie C. M. Boonen et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Steger‐Hartmann Germany	23	761	482	447	363	347	58	2.4k
Christine L. Russom United States	21	1.0k 1.3×	1.1k 2.2×	2.0k 4.6×	600 1.7×	154 0.4×	31	3.7k
John Ashby United Kingdom	37	473 0.6×	605 1.3×	2.5k 5.6×	1.5k 4.1×	96 0.3×	176	6.0k
Mark Hewitt United Kingdom	23	198 0.3×	473 1.0×	355 0.8×	273 0.8×	125 0.4×	42	1.6k
Sharon Munn Italy	17	317 0.4×	416 0.9×	1.1k 2.4×	481 1.3×	129 0.4×	24	2.3k
Marilyn J. Aardema United States	40	407 0.5×	267 0.6×	1.6k 3.6×	1.8k 5.0×	277 0.8×	98	5.0k
Michael L. Gargas United States	37	417 0.5×	317 0.7×	2.1k 4.7×	640 1.8×	35 0.1×	101	4.6k
M.E. Meek Canada	27	373 0.5×	417 0.9×	1.8k 3.9×	580 1.6×	78 0.2×	99	3.6k
Michael D. Waters United States	41	385 0.5×	289 0.6×	1.4k 3.1×	1.8k 5.0×	78 0.2×	129	4.9k
Francesco Barbato Italy	30	477 0.6×	357 0.7×	755 1.7×	861 2.4×	87 0.3×	77	2.8k
Partha Pratim Roy India	26	132 0.2×	1.7k 3.5×	177 0.4×	1.1k 3.1×	238 0.7×	99	3.8k

Countries citing papers authored by Thomas Steger‐Hartmann

Since Specialization

Citations

This map shows the geographic impact of Thomas Steger‐Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Steger‐Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Steger‐Hartmann more than expected).

Fields of papers citing papers by Thomas Steger‐Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Steger‐Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Steger‐Hartmann. The network helps show where Thomas Steger‐Hartmann may publish in the future.

Co-authorship network of co-authors of Thomas Steger‐Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Steger‐Hartmann. A scholar is included among the top collaborators of Thomas Steger‐Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Steger‐Hartmann. Thomas Steger‐Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beilmann, Mario, Karissa Adkins, Harrie C. M. Boonen, et al.. (2025). Application of new approach methodologies for nonclinical safety assessment of drug candidates. Nature Reviews Drug Discovery. 24(9). 705–725. 7 indexed citations

Vieira-Vieira, Carlos H., et al.. (2024). Replacing concurrent controls with virtual control groups in rat toxicity studies. Regulatory Toxicology and Pharmacology. 148. 105592–105592. 10 indexed citations

Hilpert, Jan, Laura Bennett, Catriona L. K. Barnes, et al.. (2023). Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis. Drugs in R&D. 23(3). 221–237. 10 indexed citations

Steger‐Hartmann, Thomas, Annika Kreuchwig, Ken Wang, et al.. (2023). Perspectives of data science in preclinical safety assessment. Drug Discovery Today. 28(8). 103642–103642. 7 indexed citations

Steger‐Hartmann, Thomas, et al.. (2023). Hurdles and signposts on the road to virtual control groups—A case study illustrating the influence of anesthesia protocols on electrolyte levels in rats. Frontiers in Pharmacology. 14. 1142534–1142534. 11 indexed citations

Steger‐Hartmann, Thomas & Marian Raschke. (2020). Translating in vitro to in vivo and animal to human. Current Opinion in Toxicology. 23-24. 6–10. 17 indexed citations

Macmillan, Donna S., Thomas Steger‐Hartmann, Jedd Hillegass, et al.. (2018). Making reliable negative predictions of human skin sensitisation using an in silico fragmentation approach. Regulatory Toxicology and Pharmacology. 95. 227–235. 19 indexed citations

Raschke, Marian, Tobias Hasenberg, Kerstin Schirrmann, et al.. (2018). Simultaneous evaluation of anti-EGFR-induced tumour and adverse skin effects in a microfluidic human 3D co-culture model. Scientific Reports. 8(1). 15010–15010. 64 indexed citations

Steger‐Hartmann, Thomas, et al.. (2017). The Future of Stem Cells and Toxicity Screening. 3(2). 149–153. 1 indexed citations

10.

Briggs, Katharine, Chris Barber, Montserrat Cases, Philippe Marc, & Thomas Steger‐Hartmann. (2014). Value of shared preclinical safety studies – The eTOX database. Toxicology Reports. 2. 210–221. 18 indexed citations

11.

Steger‐Hartmann, Thomas, et al.. (2012). Toxicological Safety Evaluation of Gadobutrol. Investigative Radiology. 47(11). 611–623. 21 indexed citations

12.

Steger‐Hartmann, Thomas, et al.. (2010). Incorporation of in silico biodegradability screening in early drug development—a feasible approach?. Environmental Science and Pollution Research. 18(4). 610–619. 6 indexed citations

13.

Pietsch, Hubertus, Philipp Lengsfeld, Jakob Walter, et al.. (2009). Evaluating the role of zinc in the occurrence of fibrosis of the skin: A preclinical study. Journal of Magnetic Resonance Imaging. 30(2). 374–383. 18 indexed citations

14.

Steger‐Hartmann, Thomas, et al.. (2006). The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process. Regulatory Toxicology and Pharmacology. 45(3). 223–228. 11 indexed citations

15.

Judson, Philip N., Paul Cooke, Nancy G. Doerrer, et al.. (2005). Towards the creation of an international toxicology information centre. Toxicology. 213(1-2). 117–128. 37 indexed citations

16.

Länge, R., et al.. (2002). Morphological sex reversal upon short-term exposure to endocrine modulators in juvenile fathead minnow (Pimephales promelas). Toxicology Letters. 131(1-2). 51–63. 71 indexed citations

17.

Steger‐Hartmann, Thomas, et al.. (2002). Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium. Water Research. 36(1). 266–274. 63 indexed citations

18.

Steger‐Hartmann, Thomas, et al.. (2000). Specific Detection of Membrane-Toxic Substances with a Conductivity Assay. Ecotoxicology and Environmental Safety. 45(3). 228–235. 11 indexed citations

19.

Steger‐Hartmann, Thomas, R. Länge, & Hermann Schweinfurth. (1999). Environmental Risk Assessment for the Widely Used Iodinated X-Ray Contrast Agent Iopromide (Ultravist). Ecotoxicology and Environmental Safety. 42(3). 274–281. 127 indexed citations

20.

Steger‐Hartmann, Thomas, Klaus Kümmerer, & Andreas Hartmann. (1997). Biological Degradation of Cyclophosphamide and Its Occurrence in Sewage Water. Ecotoxicology and Environmental Safety. 36(2). 174–179. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact